Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
 
Email
gmslwtd@nus.edu.sg
 

Publications

Results 21-40 of 47 (Search time: 0.018 seconds).

Issue DateTitleAuthor(s)
212-Dec-2022Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypesYin, Xin; Lai, Gillianne Geet Yi ; Seow, Adeline; Tan, Daniel Shao Weng ; Lim, Darren Wan-Teck ; Seow, Wei Jie 
22Jun-2023Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case ReportSaw, Stephanie Pei Li ; Lim, Darren Wan-Teck 
231-Sep-2021Dysfunctional bronchial cilia are a feature of Chronic Obstructive Pulmonary Disease (COPD)Biju Thomas ; Mariko Siyue Koh ; Chris O'Callaghan; JOHN ALLEN ; Andrew Rutman; Rob Hirst; John Connolly ; Su Ying Low ; Ong Thun How ; Loo Chian Min ; Darren Wan Teck Lim ; Oon Lin Ean Lynette ; Qixian He; Oon Hoe Teoh ; Therese Lapperre 
242018Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingNahar, R; Zhai, W; Zhang, T; Takano, A; Khng, A.J; Lee, Y.Y; Liu, X; Lim, C.H; Koh, T.P.T; Aung, Z.W; Lim, T.K.H ; Veeravalli, L; Yuan, J; Teo, A.S.M; Chan, C.X; Poh, H.M; Chua, I.M.L; Liew, A.A; Lau, D.P.X; Kwang, X.L; Toh, C.K; Lim, W.-T ; Lim, B; Tam, W.L ; Tan, E.-H ; Hillmer, A.M; Tan, D.S.W
2510-Jan-2017Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion StudyNogova, Lucia; Sequist, Lecia V; Garcia, Jose Manuel Perez; Andre, Fabrice; Delord, Jean-Pierre; Hidalgo, Manuel; Schellens, Jan HM; Cassier, Philippe A; Camidge, D Ross; Schuler, Martin; Vaishampayan, Ulka; Burris, Howard; Tian, G Gary; Campone, Mario; Wainberg, Zev A; Lim, Wan-Teck ; LoRusso, Patricia; Shapiro, Geoffrey I; Parker, Katie; Chen, Xueying; Choudhury, Somesh; Ringeisen, Francois; Graus-Porta, Diana; Porter, Dale; Isaacs, Randi; Buettner, Reinhard; Wolf, Juergen
2630-Mar-2021Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutationsChang, Gee-Chen; Lam, David Chi-Leung; Tsai, Chun-Ming; Chen, Yuh-Min; Shih, Jin-Yuan; Aggarwal, Shyam; Wang, Shuhang; Kim, Sang-We; Kim, Young-Chul; Wahid, Ibrahim; Li, Rubi; Lim, Darren Wan-Teck ; Sriuranpong, Virote; Chan, Raymond Tsz-Tong; Lorence, Robert M; Carriere, Philippe; Raabe, Christina; Cseh, Agnieszka; Park, Keunchil
27Aug-2021First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas.Piha-Paul, Sarina A; Geva, Ravit; Tan, Tira J ; Lim, Darren Wt ; Hierro, Cinta; Doi, Toshikiko; Rahma, Osama; Lesokhin, Alexander; Luke, Jason John; Otero, Javier; Nardi, Lisa; Singh, Angad; Xyrafas, Alexandros; Chen, Xinhui; Mataraza, Jennifer; Bedard, Philippe L
281-Jan-2020First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology DrugTeneggi, V; Novotny-Diermayr, V; Lee, LH; Yasin, M; Yeo, P; Ethirajulu, K; Gan, SBH; Blanchard, SE; Nellore, R; Umrani, DN; Gomeni, R; Teck, DLW ; Li, G; Lu, QS; Cao, Y; Matter, A 
292015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. 
30May-2021Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceSeet, Amanda OL; Tan, Aaron C ; Tan, Tira J ; Ng, Matthew CH; Tai, David WM ; Lam, Justina YC ; San Tan, Gek ; Gogna, Apoorva ; Too, Chow Wei ; Tan, Bien Soo ; Takano, Angela ; Lim, Alvin ; Lim, Tse Hui ; Lim, Soon Thye ; Dent, Rebecca Alexandra ; Ang, Mei Kim ; Yap, Yoon-Sim ; Tan, Iain BH; Choo, Su Pin ; Toh, Chee Keong ; Lim, Elaine H ; Farid, Mohamad; Skanderup, Anders Jacobsen ; Iyer, N Gopalakrishna ; Lim, Wan Teck ; Tan, Eng Huat ; Lim, Tony KH; Tan, Daniel SW 
313-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
121-Nov-2021Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesChua, Khi Pin; Teng, Yvonne HF ; Tan, Aaron C ; Takano, Angela ; Alvarez, Jacob JS; Nahar, Rahul; Rohatgi, Neha; Lai, Gillianne GY ; Aung, Zaw Win; Yeong, Joe PS; Lim, Kiat Hon ; Naeini, Marjan Mojtabavi; Kassam, Irfahan ; Jain, Amit ; Tan, Wan Ling ; Gogna, Apoorva ; Too, Chow Wei ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Anantham, Devanand ; Phua, Ghee Chee ; Tan, Bien Soo ; Lee, Yin Yeng; Wang, Lanying; Teo, Audrey SM; Khng, Alexis Jiaying; Lim, Ming Jie ; Suteja, Lisda; Toh, Chee Keong ; Lim, Wan-Teck ; Iyer, N Gopalakrishna ; Tam, Wai Leong ; Tan, Eng-Huat ; Zhai, Weiwei; Hillmer, Axel M; Skanderup, Anders J ; Tan, Daniel SW 
1317-Jul-2023Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerLee, Ning-Yuan; Hum, Melissa ; Zihara, Sabna; Wang, Lanying; Myint, Matthew K ; Lim, Darren Wan-Teck ; Toh, Chee-Keong ; Skanderup, Anders ; Samol, Jens; Tan, Min-Han ; Ang, Peter; Lee, Soo-Chin ; Tan, Eng-Huat ; Lai, Gillianne GY ; Tan, Daniel SW ; Yap, Yoon-Sim ; Lee, Ann SG 
1429-Feb-2016Microfluidic enrichment for the single cell analysis of circulating tumor cellsYeo, Trifanny ; Tan, Swee Jin; Lim, Chew Leng; Lau, Dawn Ping Xi; Chua, Yong Wei; Krisna, Sai Sakktee; Iyer, Gopal ; Tan, Gek San ; Lim, Tony Kiat Hon; Tan, Daniel SW ; Lim, Wan-Teck ; Lim, Chwee Teck 
15Jun-2020Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trialSchuler, M; Berardi, R; Lim, W-T ; de Jonge, M; Bauer, TM; Azaro, A; Gottfried, M; Han, J-Y; Lee, DH; Wollner, M; Hong, DS; Vogel, A; Delmonte, A; Akimov, M; Ghebremariam, S; Cui, X; Nwana, N; Giovannini, M; Kim, TM
1622-May-2019Pan-cancer analysis connects tumor matrisome to immune responseLim, Su Bin; Chua, Melvin Lee Kiang ; Yeong, Joe Poh Sheng; Jin, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
1730-Dec-2019Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsBang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck ; Bauer, Todd M; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette
181-Jun-2018Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCTan, Eng-Huat ; Lim, Wan-Teck ; Ahn, Myung-Ju; Ng, Quan-Sing ; Ahn, Jin Seok; Tan, Daniel Shao-Weng ; Sun, Jong-Mu; Han, May; Payumo, Francis C; Mckee, Krista; Yin, Wei; Credi, Marc; Agarwal, Shefali; Jac, Jaroslaw; Park, Keunchil
192016Phase I study of oral vinorelbine in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) using two different schedulesSutiman N.; Zhang Z.; Ang M.K. ; Tan S.-W.D.; Toh C.K.; Ng Q.S.; Chowbay B. ; Lim W.-T. 
202011'Prechronous' metastasis in clear cell renal cell carcinoma: A case reportPoon, E; Ong, S.J ; Chuang, X.E; Lim, W.T ; Mohd Zam, N.A ; Chong, T.W ; Al Jajeh, I; Mancer, K; Tan, M.-H